Proof: Claims with Studies
Additional References - CissoLean™This page provides the detail reference between the CissoLean™ claims and the evidence in scientific studies. 1 – Helps Reduce Body Weight and Burn FatThe use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis. 2008 Mar 31;7:12. The Use of a Cissus Quadrangualris / Irvingia Gabonesis Combination in Weight Management in Human Volunteers: A Pilot Study. 2nd World Congress on Prevention and Therapies Against Obesity: Innovations and Perspectives. Institut Pasteur, Paris France June 14-15, 2007. Abstract
2 – Clinically Proven Weight Loss up to 19 lbs in 10 Weeks.The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis. 2008 Mar 31;7:12. 3 – Help Reduce BMI and Builds Lean Muscle up to 4 inches in 10 WeeksThe use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis. 2008 Mar 31;7:12. 4 – The Recommended Daily Dosage of CissusThe use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis. 2008 Mar 31;7:12. The effect of Cissus quadrangularis (CQR-300) and a Cissus formulation (CORE) on obesity and obesity-induced oxidative stress. Lipids Health Dis. 2007 Feb 4;6:4. The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome. Lipids Health Dis. 2006 Sep 2;5:24. The effect of Cissus quadrangularis (Cissus™) on weight and serum lipids in obese patients in Cameroon: a randomized double blind clinical trial. 1st World Congress on Prevention and Therapies Against Obesity: Perspectives for Pharmaceutical and Natural Products. Institut Pasteur, Paris France May 18-19, 2006. Abstract 5 – Hours of Energy / Caffeine and B-VitaminsThe effect of Cissus quadrangularis (CQR-300) and a Cissus formulation (CORE) on obesity and obesity-induced oxidative stress. Lipids Health Dis. 2007 Feb 4;6:4. The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome. Lipids Health Dis. 2006 Sep 2;5:24. 6 – Clinical Studies Where People Were not put on a Special Diet and Exercise ProgramThe use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis. 2008 Mar 31;7:12. 7 – Safe, When Used As DirectedThe use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis. 2008 Mar 31;7:12. The Use of a Cissus Quadrangualris/ Irvingia Gabonesis Combination in Weight Management in Human Volunteers: A Pilot Study. 2nd World Congress on Prevention and Therapies Against Obesity: Innovations and Perspectives. Institut Pasteur, Paris France June 14-15, 2007. Abstract The effect of Cissus quadrangularis (CQR-300) and a Cissus formulation (CORE) on obesity and obesity-induced oxidative stress. Lipids Health Dis. 2007 Feb 4;6:4. The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome. Lipids Health Dis. 2006 Sep 2;5:24. The effect of Cissus quadrangularis (Cissus™) on weight and serum lipids in obese patients in Cameroon: a randomized double blind clinical trial. 1stWorld Congress on Prevention and Therapies Against Obesity: Perspectives forPharmaceutical and Natural Products. Institut Pasteur, Paris France May 18-19,2006. Abstract 8 – Helps Maintain Healthy Cholesterol Levels and Promotes Cardiovascular HealthThe use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis. 2008 Mar 31;7:12. The Use of a Cissus Quadrangualris/ Irvingia Gabonesis Combination in Weight Management in Human Volunteers: A Pilot Study. 2nd World Congress on Prevention and Therapies Against Obesity: Innovations and Perspectives. Institut Pasteur, Paris France June 14-15, 2007. Abstract Enzyme inhibition by aqueous extracts and fractions of Cissus quadrangularis: Application in the management of obesity and related complications. 2nd World Congress on Prevention and Therapies Against Obesity: Innovations and Perspectives. Institut Pasteur, Paris France June 14-15, 2007. Abstract The effect of Cissus quadrangularis (CQR-300) and a Cissus formulation (CORE) on obesity and obesity-induced oxidative stress. Lipids Health Dis. 2007 Feb 4;6:4. Inhibitory Effects of Cissus quadrangularis L. Derived Components on Lipase, Amylase and alpha-Glucosidase Activity in vitro. Natural Product Communications 2007 2;8:817-22. The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome. Lipids Health Dis. 2006 Sep 2;5:24. The effect of Cissus quadrangularis (Cissus™) on weight and serum lipids in obese patients in Cameroon: a randomized double blind clinical trial. 1st World Congress on Prevention and Therapies Against Obesity: Perspectives for Pharmaceutical and Natural Products. Institut Pasteur, Paris France May 18-19, 2006. Abstract 9 – Promotes Healthy Blood Sugar LevelsThe use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis. 2008 Mar 31;7:12. The Use of a Cissus Quadrangualris/ Irvingia Gabonesis Combination in Weight Management in Human Volunteers: A Pilot Study. 2nd World Congress on Prevention and Therapies Against Obesity: Innovations and Perspectives. Institut Pasteur, Paris France June 14-15, 2007. Abstract Enzyme inhibition by aqueous extracts and fractions of Cissus quadrangularis: Application in the management of obesity and related complications. 2nd World Congress on Prevention and Therapies Against Obesity: Innovations and Perspectives. Institut Pasteur, Paris France June 14-15, 2007. Abstract The effect of Cissus quadrangularis (CQR-300) and a Cissus formulation (CORE) on obesity and obesity-induced oxidative stress. Lipids Health Dis. 2007 Feb 4;6:4. Inhibitory Effects of Cissus quadrangularis L. Derived Components on Lipase, Amylase and alpha-Glucosidase Activity in vitro. Natural Product Communications 2007 2;8:817-22. The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome. Lipids Health Dis. 2006 Sep 2;5:24. The effect of Cissus quadrangularis (Cissus™) on weight and serum lipids in obese patients in Cameroon: a randomized double blind clinical trial. 1st World Congress on Prevention and Therapies Against Obesity: Perspectives for Pharmaceutical and Natural Products. Institut Pasteur, Paris France May 18-19, 2006. Abstract Where to next...
Statements made by Natura Health Portal Inc. / cissolean.com have not been evaluated by the Food and Drug Administration (FDA). The FDA does not evaluate or test herbs. These products are not intended to diagnose, treat, cure or prevent any illness or disease. Consult with your physician for diagnosis or treatment. Use herbs as per instructions and always watch for any allergic reactions. |
